(Q44387351)

2 December 2017

title

Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin (English)

1 reference

2 December 2017

Eleni V Dimaraki

1

1 reference

2 December 2017

Craig A Jaffe

2

1 reference

2 December 2017

Cyril Y Bowers

3

1 reference

2 December 2017

Peter Marbach

4

1 reference

2 December 2017

Ariel L Barkan

5

1 reference

2 December 2017

publication date

1 April 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

2 December 2017

published in

1 reference

2 December 2017

volume

285

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

E163-70

1 reference

Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Growth hormone-releasing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Regulatory mechanisms of growth hormone secretion are sexually dimorphic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Effect of somatostatin withdrawal and growth hormone (GH)-releasing factor on GH release in vitro: amount available for release after disinhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rams

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Ghrelin immunoreactivity in human plasma is suppressed by somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Sexual Dimorphism of Somatostatin and Growth Hormone-Releasing Factor Signaling in the Control of Pulsatile Growth Hormone Secretion in the Rat*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Interaction of Somatostatin Inhibition and Dibutyryl Cyclic AMP or Potassium Stimulation of Growth Hormone Release from Perifused Rat Pituitaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Deconvolution analysis of hormone data

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00334.2002

10.1152/AJPENDO.00334.2002

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference